跳至主要内容
临床试验/CTRI/2022/06/043269
CTRI/2022/06/043269已完成2 期

A Randomized Clinical Trial to evaluate the efficacy of Khadirakramuka Kwath and Nishamlaki Per Orum with and without Nitya Virechana in the management of Pramehajanya Timira with special reference to Diabetic Macular Edema

ational Institute of Ayurveda0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients between 40-70 years of age.
  • 2.Diagnosed cases of Diabetes Mellitus Type 2.
  • 3.NPDR cases with Macular Edema.
  • 4.Clinically significant Diabetic Macular
  • Edema of less than 12 months duration.
  • 5.Visual acuity minimum 6/60 or better.
  • 6.Patients having HbA1c levels upto 8.

排除标准

  • 1.Hypertensive patients with systolic BP >160
  • and diastolic BP >95 mm Hg.
  • 2.Patients having HbA1c levels greater than
  • 3.Diabetic patients with cardiovascular
  • 4.History of ocular surgery within 4 months
  • prior to enrolment.
  • 5.Pregnant diabetic patients.
  • 6.Patients with moderate to severe
  • cataractous changes.
  • 7.Patients having a history of glaucoma or
  • on-going treatment of glaucoma.

研究者

相似试验

To study the effect of Ayurvedic formulations on... | 临床试验